5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids.
about
Cardiotoxicity in childhood cancer survivors: strategies for prevention and managementTargeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issueDiazoxide protects against doxorubicin-induced cardiotoxicity in the rat.Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts.Cardiac mitochondria and arrhythmias.The role of mitochondria in protection of the heart by preconditioning.Mitochondria are sources of metabolic sink and arrhythmias.Ischemia reperfusion injury, KATP channels, and exercise-induced cardioprotection against apoptosisKATP Channels in the Cardiovascular System.NRF2 and the Phase II Response in Acute Stress Resistance Induced by Dietary Restriction.The mitochondrial K(ATP) channel--fact or fiction?Perspectives in innate and acquired cardioprotection: cardioprotection acquired through exercise.Exercise and cardiac preconditioning against ischemia reperfusion injury.Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning.The role of ATP-sensitive potassium channels in cellular function and protection in the cardiovascular systemMitochondrial channels: ion fluxes and more.The Slo(w) path to identifying the mitochondrial channels responsible for ischemic protection.Targeted expression of Kir6.2 in mitochondria confers protection against hypoxic stress.Mitochondrial biotransformation of omega-(phenoxy)alkanoic acids, 3-(phenoxy)acrylic acids, and omega-(1-methyl-1H-imidazol-2-ylthio)alkanoic acids: a prodrug strategy for targeting cytoprotective antioxidants to mitochondria.Nitro-fatty acid metabolome: saturation, desaturation, beta-oxidation, and protein adduction.Effect of HEMADO on Level of CK-MB and LDH Enzymes after Ischemia/Reperfusion Injury in Isolated Rat Heart.epsilonPKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus.Modulation of mitochondrial respiratory function and ROS production by novel benzopyran analogues.Intermittent insulin treatment mimics ischemic postconditioning via MitoKATP channels, ROS, and RISK.Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: a study on Langendorff-perfused rat hearts using optic fibers.Cardioprotection afforded by chronic exercise is mediated by the sarcolemmal, and not the mitochondrial, isoform of the KATP channel in the rat.Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion.Effect of dexmedetomidine on cerebral ischemia-reperfusion rats by activating mitochondrial ATP-sensitive potassium channel.Comparison of effects of ATP-gated potassium channel blockers on activity variations of rat CA1 pyramidal neurons in hippocampal slices triggered by short-term hypoxia.Pretreatment with brain natriuretic peptide reduces skeletal muscle mitochondrial dysfunction and oxidative stress after ischemia-reperfusion.Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation.K+-independent actions of diazoxide question the role of inner membrane KATP channels in mitochondrial cytoprotective signaling.
P2860
Q24628695-717FB909-12C4-4480-ABF8-4456CBC48A42Q26852041-85448E97-2A31-4EAF-99A3-8ED453583FCBQ33712631-FE4F0839-7D1B-4312-9695-14BA0BEA472BQ33994857-24ED8BA9-BFDF-4BD0-83BB-651334ACA5C6Q34307966-A59C1A5A-D91D-4A7A-BFF6-526407121B2BQ34581118-45B1CF05-A815-4289-A42B-FFE27D013129Q35111783-36752139-74E2-46CF-B717-F5719C3426EAQ36184567-D23E7669-018B-4C19-AB13-4D7A968244F9Q36422478-8A09CD8B-5672-4ED6-85AA-4F06DD14E3A8Q36678635-0E1BC409-372E-48FB-B6A0-B04553A69F32Q36744211-A6880113-2B9A-464E-89D8-5EF18C2FCD3AQ36843601-084E0358-5B0A-49FB-B2C0-5575FB3C8A08Q37190421-BF4433DC-26B6-40DE-88DA-3046B44907E8Q37225972-752EDB5B-AAE5-4C0B-A46D-C67B12F716D7Q37418212-1A75BC1F-221A-4A59-9705-E88CD31E4F95Q38201407-802C4DBE-AC19-49C1-99CF-E9B4AF0E9C3EQ39363477-B4391EA4-3D3D-4993-A947-B06A6890A541Q40234404-16A511A8-9590-4DA6-9C68-3C8C421DB0A1Q41126212-3925FF18-CDAA-448F-BE2B-42AEC4C18109Q41995295-E42F9B1C-EB2E-4401-BB03-2F8CE8BC2339Q43088380-AE84F2D0-06BC-42DD-B89E-0385A7941FB4Q43247175-06E04531-38EE-4A96-89C2-68D7F57568B5Q46676435-BEF41D53-D34E-4A85-A4A5-3AF1F92B2438Q46703356-580C2380-6E2F-4E3B-A1F1-55D04C61B154Q46736430-24383414-FC85-4163-8C09-793F05B4141DQ46751806-FDF996B1-F2F9-455E-B1B3-1BA137AD274DQ46788973-466957A9-7E41-42B6-BE9B-A733B86219BFQ48107123-F8018A9F-A189-4C3B-B367-0E4140ECB635Q48128370-B24ADFEC-B741-4CC7-9528-EC5CE0F45324Q48318026-568B186C-27A6-475E-86B5-9E07E162FD02Q48630672-3D1F5B53-2D61-417D-BC0D-72B552AFC758Q50734246-3E364F99-1B5E-4D97-8590-B1F890B2A2E1
P2860
5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
5-Hydroxydecanoate is metaboli ...... beta-oxidation of fatty acids.
@en
5-Hydroxydecanoate is metaboli ...... beta-oxidation of fatty acids.
@nl
type
label
5-Hydroxydecanoate is metaboli ...... beta-oxidation of fatty acids.
@en
5-Hydroxydecanoate is metaboli ...... beta-oxidation of fatty acids.
@nl
prefLabel
5-Hydroxydecanoate is metaboli ...... beta-oxidation of fatty acids.
@en
5-Hydroxydecanoate is metaboli ...... beta-oxidation of fatty acids.
@nl
P2093
P2860
P921
P1476
5-Hydroxydecanoate is metaboli ...... beta-oxidation of fatty acids.
@en
P2093
Abir L Banerjee
D K Srivastava
Joseph J Barycki
Jürgen Daut
Leonard J Banaszak
Paul P Van Veldhoven
Peter J Hanley
Rachel A Lareau
Stefan Dröse
P2860
P304
P356
10.1113/JPHYSIOL.2004.073932
P407
P577
2004-10-28T00:00:00Z